APA (7th ed.) Citation

Miaomiao Yang, Xiongying Jiang, Huan Liu, Qingyu Zhang, Jing Li, Li Shao, & Lei Zhao. (2024). Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Miaomiao Yang, Xiongying Jiang, Huan Liu, Qingyu Zhang, Jing Li, Li Shao, and Lei Zhao. Efficacy and Safety of HAIC Combined with Tyrosine Kinase Inhibitors Versus HAIC Monotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Miaomiao Yang, et al. Efficacy and Safety of HAIC Combined with Tyrosine Kinase Inhibitors Versus HAIC Monotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis. Frontiers Media S.A., 2024.